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ABSTRACT
CRISPR-Cas is an RNA-mediated adaptive immune system that defends bacteria and archaea against mobile genetic
elements. Short mature CRISPR RNAs (crRNAs) are key elements in the interference step of the immune pathway. A CRISPR
array composed of a series of repeats interspaced by spacer sequences acquired from invading mobile genomes is
transcribed as a precursor crRNA (pre-crRNA) molecule. This pre-crRNA undergoes one or two maturation steps to generate
the mature crRNAs that guide CRISPR-associated (Cas) protein(s) to cognate invading genomes for their destruction.
Different types of CRISPR-Cas systems have evolved distinct crRNA biogenesis pathways that implicate highly sophisticated
processing mechanisms. In Types I and III CRISPR-Cas systems, a specific endoribonuclease of the Cas6 family, either
standalone or in a complex with other Cas proteins, cleaves the pre-crRNA within the repeat regions. In Type II systems, the
trans-acting small RNA (tracrRNA) base pairs with each repeat of the pre-crRNA to form a dual-RNA that is cleaved by the
housekeeping RNase III in the presence of the protein Cas9. In this review, we present a detailed comparative analysis of
pre-crRNA recognition and cleavage mechanisms involved in the biogenesis of guide crRNAs in the three CRISPR-Cas types.
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INTRODUCTION
CRISPR-Cas are RNA-mediated adaptive immune systems that
protect bacteria and archaea from invading mobile genetic ele-
ments (Reeks, Naismith and White 2013; Charpentier and Mar-
raffini 2014; van der Oost et al. 2014). The systems are composed
of an operon of CRISPR-associated (cas) genes and a CRISPR ar-
ray consisting of a leader sequence followed by a series of short
identical repeats interspaced by short unique spacer sequences.
The spacers originate from mobile genetic elements memo-
rized upon a first infection, and enable recognition of the in-
vading elements upon a second infection (Barrangou et al. 2007).
The CRISPR-Cas systems are highly variable in their cas gene
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Figure 1. cas gene composition of the CRISPR-Cas systems. Loci from Types I-A to I-F, Types II-A to II-C and Types III-A and II-B CRISPR-Cas systems are represented.
The CRISPR arrays are composed of a series of repeats (black diamonds) interspaced by invading genome-targeting spacers (colored diamonds). An operon of cas genes
is located in the close vicinity of the CRISPR array. The Cas proteins involved in the crRNA biogenesis in Types I-A, I-B, I-D, I-E and I-F and Types III-A and III-B belong
to the Cas6 family. An exception is the gene product Cas5d responsible for the processing of pre-crRNA in Type I-C. In Type II systems, tracrRNA, and the proteins Cas9
and RNase III are the three components responsible for pre-crRNA maturation.
composition, and a classification has resulted into three
main CRISPR-Cas types that are further divided into subtypes
(Makarova et al. 2011a,b) (Fig. 1). Despite the cas gene diversi-
fication, all systems share a common molecular principle for
genome silencing in which the mature CRISPR RNAs (crRNAs)
contain a (partially) unique spacer (invader-derived) sequence
that guides one or more Cas protein(s) to cognate invading nu-
cleic acids for their eventual destruction after sequence-specific
recognition.
The maturation of the crRNAs is critical for the activity of
the system and the biogenesis of mature crRNAs can be divided
into three steps. First, a long primary transcript or precursor cr-
RNA (pre-crRNA) is generated from a promoter located within
the leader sequence that precedes the CRISPR repeat-spacer ar-
ray. Next, primary cleavage of the pre-crRNA occurs at a specific
site within the repeats to yield crRNAs that consist of the entire
spacer sequence flanked by partial repeat sequences. In some
cases, an additional secondary cleavage step is required to gen-
erate the active mature crRNAs.
Distinct mechanisms of crRNA biogenesis have evolved, re-
flected by the diversification of CRISPR-Cas into various sub-
types and the large panel of distinct Cas proteins. A common
theme among the CRISPR-Cas types is the transcription of the
pre-crRNA and the first processing event within the repeats. In
Types I and III, a protein of the Cas6 family or alternatively Cas5d
catalyzes this step (Figs 2 and 4). In Type II, a trans-acting small
RNA directs pre-crRNA dicing by housekeeping endoribonucle-
ase III-mediated cleavage within the repeats in the presence of
Cas9 (Fig. 3). The processed crRNAs from Types I-C, I-E and I-F
do not undergo further maturation, whereas in at least Types
I-A, I-B and I-D, as well as in Types II and III, a second mat-
uration step produces the active crRNAs, the components and
mechanisms of which are yet to be determined (Figs 2–4). In this
review, we describe and provide a comparative analysis of the
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Figure 2. crRNA processing pathways in Type I CRISPR-Cas systems. In Type I systems, the palindromic repeats in the pre-crRNA are either unstructured (Cascade/I-
A, Cascade/I-B) or form hairpin structures (Cascade/I-C, Cascade/I-D, Cascade/I-E, Cascade/I-F) that are recognized by the nuclease Cas6 (Cas6a, Cascade/I-A; Cas6b,
Cascade/I-B; Cas6d, Cascade/I-D; Cas6e, Cascade/I-E; Cas6f, Cascade/I-F) or Cas5 (Cas5d, Cascade/I-C). After cleavage, the crRNA hairpin remains associated with
Cas6 or Cas5 whilst other subunits bind the 5′ handle and spacer, which is used for the recognition of cognate genetic element sequences by the respective Cascade
complexes.
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Figure 3. crRNA processing pathways in Type II CRISPR-Cas systems. In Type II systems, the precursor transcript of the CRISPR repeat-spacer array forms duplexes with
the trans-activating tracrRNA through pre-crRNA repeat:tracrRNA anti-repeat interactions. The duplex RNAs stabilized by the protein Cas9 are recognized and cleaved
by the bacterial endoribonuclease III (RNase III). A second processing by unknown nucleases (trimming by an exonuclease and/or cleavage by an endoribonuclease)
generates themature crRNAs. An alternative pathway for the production ofmature crRNAswas described in a Type II-C ofN.meningitidis. Here, the transcription of short
crRNAs occurs directly from promoters contained within the repeats of the array, and thus independently of cleavage by RNase III. The mature dual tracrRNA:crRNAs
complexed with the protein Cas9 form the interference complex that target and cleave site specifically double-stranded DNA.
remarkable crRNA maturation processes that have evolved in
the three CRISPR-Cas types.
crRNA BIOGENESIS IN TYPE I SYSTEMS
Type I systems are present in both bacteria and archaea
(Makarova et al. 2011a,b). Like all CRISPR-Cas systems, Types I
have been shown to target mobile genetic sequences. First, ex-
perimental evidence for spacer acquisition by Type I systems
has been provided in Escherichia coli (Type I-E), with the corre-
lating resistance against plasmids (Swarts et al. 2012; Yosef et al.
2012) and phages (Datsenko et al. 2012). The Type I-F system of
Pseudomonas aeruginosa has been linked to inhibition of biofilm
formation, the effect being most probably indirect and depend-
ing on an integrated bacteriophage (Cady and O’Toole 2011),
whereas its role in the maintenance of phage resistance is yet
to be demonstrated (Cady et al. 2012). Type I systems are char-
acterized by the CRISPR-associated ribonucleoprotein (crRNP)
complex for antiviral defense (Cascade) and a nuclease/helicase
(Cas3) that are both required for interference (Brouns et al. 2008).
Processing of the pre-crRNA transcript is catalyzed by the family
of Cas6 metal-independent endoribonucleases that cleave the
repeat sequence at a conserved position typically 8 nt upstream
of the repeat-spacer boundary (Brouns et al. 2008; Carte et al.
2008). Once maturated, the crRNAs bound to Cascade play the
crucial role of guiding the complex to a complementary target
DNA. In Type I-E and I-F systems, the Cas6 enzymes are a sub-
unit of a Cascade-like complex (Jore et al. 2011; Wiedenheft et al.
2011a,b). This is different from the apparent standalone version
of Cas6 that most likely supplies the intermediate or mature cr-
RNAs to different complexes in Type I-A and Type III systems
(see below, ‘crRNA biogenesis in Type III’). The crRNAs of Types
I-C, I-D, I-E and I-F have stable hairpin structures, which func-
tion to initially expose the cleavage site to the Cas6 (or Cas5d
in Type I-C) catalytic domain, and to subsequently assist in the
stable interaction between guide crRNA and Cascade. Follow-
ing Cas6-mediated cleavage within the repeats, crRNAs of Types
I-C, I-E and I-F are not processed any further (Jore et al. 2011;
Wiedenheft et al. 2011a,b; Nam et al. 2012).
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Figure 4. crRNA processing pathways in Type III CRISPR-Cas systems. In Type III-A and III-B systems, the standalone Cas6 endonuclease binds unstructured pre-crRNA
and cleaves within each repeat to generate intermediate crRNAs with 5′ and 3′ repeat-derived termini. The crRNAs are loaded into the Csm (Type III-A) or Cmr (Type
III-B) complex and undergo further maturation through trimming of the 3′ repeat-derived sequence by nucleases that are yet to be identified.
Type I crRNAs are expressed and processed in vivo
Expression of Type I crRNAs has been demonstrated amongst
others in Sulfolobus solfataricus and Thermoproteus tenax (I-A),
Clostridium thermocellum and Methanococcus maripaludis (I-B), E.
coli and Thermus thermophilus (I-E), P. aeruginosa (I-F) and Nanoar-
chaeum equitans (Brouns et al. 2008; Haurwitz et al. 2010; Jore et al.
2011; Lintner et al. 2011; Juranek et al. 2012; Randau 2012; Richter
et al. 2012; Zoephel and Randau 2013; Plagens et al. 2014). Type
I-A loci are characterized by the presence of cas6a, located in
proximity to an operon typically composed of cas1, cas2, cas4,
csa1, csa5, cas8a1 or cas8a2, cas7 (csa2), cas5, cas3′ and cas3′′. The
archaeon S. solfataricus was shown to express Type I-A crRNAs
of 60–70 nt bound to a Cascade-like protein complex (Lintner
et al. 2011). Expression of Type I-A crRNAs processed from larger
transcripts with subsequent trimming events was also detected
in the hyperthermophilic crenarchaeon T. tenax (Plagens et al.
2012, 2014). A Type I-B locus contains the gene cas6b followed
by the genes cas8b, cas7, cas5, cas3, cas1, cas2 and cas4. Expres-
sion and processing of Type I-B pre-crRNAs were detected in
the bacterial species C. thermocellum and the archaeal species
M. maripaludis (Richter et al. 2012; Zoephel and Randau 2013),
Haloferax volcanii (Fischer et al. 2012), H. mediterranei (Li et al. 2013)
and M. mazeii (Nickel et al. 2013). Interestingly, RNAs antisense
to crRNAs, transcribed from spacer elements, were detected in
C. thermocellum, as previously described for the Type III-B sys-
tem of S. acidocaldarius (Lillestol et al. 2009) and Pyrococcus fu-
riosus (Hale et al. 2012) (see below). In Type I-D, expression of
crRNAs of varying length was detected in the cyanobacterium
Synechocystis sp. PCC6803 (Scholz et al. 2013) and was shown to
be dependent on environmental conditions (Hein et al. 2013).
Type I-E found in E. coli, for example, is specified by the pres-
ence of the Cascade genes cse1 (casA), cse2 (casB), cas7 (casC), cas5
(casD), cas6e (casE), the adaptation genes cas1 and cas2 and the
nuclease/helicase gene cas3. In 2008 and 2011, Brouns and Jore
identified crRNAs of 61 nt as mature species produced from the
Type I-E array (Brouns et al. 2008; Jore et al. 2011). The expres-
sion (i) of the Cascade (see below)-encoding cse1-cse2-cas7-cas5-
cas6e operon, (ii) of an antisense transcript to cas3mRNA and to
a certain extent (iii) of the CRISPR array is controlled by an inter-
play of the global transcriptional regulators H-NS (heat-stable
nucleoid-structuring) and LeuO (Hommais et al. 2001; Oshima
et al. 2006; Pougach et al. 2010; Pul et al. 2010; Westra et al. 2010).
In addition, the response regulator BaeR of the two-component
system BaeSR positively regulates expression of the E. coli Cas-
cade operon (Baranova and Nikaido 2002; Perez-Rodriguez et al.
2011). The Type I-F cas operon consists of the genes cas1, a cas2-
cas3 fusion, csy1, csy2, csy3 and cas6f (csy4). In P. aeruginosa, ma-
ture crRNAs of this type were visualized as 60-nt fragments by
Northern blot analysis of RNAs co-purified with Cas6f (Haurwitz
et al. 2010).
Type-I-associated Cas6 endoribonucleases cleave
the pre-crRNA within the repeats
Cas6a
Cas6 of the Type I-A system of the archaeon S. solfataricus has
a metal-independent ribonuclease activity, that is specifically
used for generating crRNAs by cleavage of template pre-crRNAs
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at a single position within the repeat, consistent with the cleav-
age site used by other Cas6 enzymes (Lintner et al. 2011). This
is also consistent with the sequencing analysis of crRNAs as-
sociated with Type I-A Cascade that revealed a composition of
an 8-nt 5′ repeat fragment followed by a complete spacer se-
quence and a varying repeat fragment at the 3′ end (Lintner
et al. 2011). The apparent differences between the Cascade sub-
complex of S. solfataricus (Lintner et al. 2011) and the complete
complex of T. tenax (Plagens et al. 2014) may suggest that Cas6
is only transiently associated to Type I-A Cascade and only de-
livers the mature crRNA to a pre-preformed subcomplex. Type
I-A Cascade complexes from the archaea S. solfataricus and T.
tenax have been analyzed in detail (Lintner et al. 2011; Plagens
et al. 2014). In S. solfataricus, Cas7 was shown to co-purifiy with
the proteins Cas5a, Cas6, Csa5 and processed forms of crRNAs,
with the dominant protein Cas7 forming a stable complex with
Cas5a (Lintner et al. 2011). For T. tenax, however, in vitro recon-
stitution of a functional Cascade did not require Cas6. The latter
was also not co-purifiedwithCsa5 (Plagens et al. 2014). Transmis-
sion electron microscopy revealed helical structures of variable
length (Lintner et al. 2011; Plagens et al. 2014), perhaps because of
substoichiometric amounts of other Cascade components, sim-
ilar to that observed with E. coli Cascade samples (Brouns, Jore
and Van der Oost unpublished). Cas7 (Csa2) was structurally an-
alyzed and shown to have a crescent-shape structure composed
of a modified RNA-recognition motif (RRM; Lintner et al. 2011),
in perfect agreement with the role of Cas7 in binding crRNAs
(Wiedenheft et al. 2011a,b; Jackson et al. 2014; Mulepati et al.
2014).
Cas6b
Cas6 proteins from Type I-B of the bacterium C. thermocellum and
the archaeon M. maripaludis were recently demonstrated to act
as endoribonucleases cleaving pre-crRNA yielding the canonical
8-nt 5′ handle (Richter et al. 2012). In these species, RNA-seq data
indicate a further trimming of the 3′ end. Biochemical analysis
showed that Cas6b requires two histidine residues for catalysis,
which is in contrast to other Cas6 family proteins that utilize
only one histidine residue (see below), suggesting more flexi-
bility in the catalytic core of Cas6b endoribonucleases (Richter
et al. 2012). Additionally, it was shown that Cas6b forms dimers
upon substrate binding although the native form of the protein
is monomeric (Richter et al. 2013). Oligomerization of Cas6 pro-
teins was also shown for Type III enzymes of P. horikoshii and S.
solfataricus (see below) (Wang et al. 2012; Reeks et al. 2013). The
formation of dimers is not unusual as other endoribonucleases
were shown to be active as multimers (Li et al. 1998; Calvin et al.
2005; Randau et al. 2005).
Cas6d
In the cyanobacterium Synechocystis sp. PCC6803, crRNAs con-
tain a typical 8-nt tag generated from cleavage of the pre-crRNA
byCas6d through recognition of the repeat structure (Scholz et al.
2013). The crRNAs in this Type I-D are of 39–45 nt in size. The 6-
nt gap between the two species may indicate that, as observed
in Type III systems, the 3′ handle of the guide is dissociated from
the Cas6-like ribonuclease, after which secondary trimming oc-
curs depending on the size of the Cas7 backbone of the complex.
Cas6e
In E. coli Type I-E, Brouns et al. (2008) were first to iden-
tify a Cas protein complex formed by Cse1, Cse2, Cas7, Cas5
and Cas6e, which was named CRISPR associated complex for
antiviral defense (Cascade). A subsequent combined genetic and
biochemical approach was used to demonstrate that mature cr-
RNAswere only producedwhen all proteins forming theCascade
complex were present (Brouns et al. 2008; Jore et al. 2011). It was
shown that the conserved nucleotide sequence of the repeats
within pre-crRNA is essential for recognition and processing by
Cas6e (Brouns et al. 2008). RNA cleavage was demonstrated to be
independent of divalent metal ions or adenosine triphosphate.
In 2006, Ebihara et al. (2006) provided the crystal structure of
Cas6e from the bacterium T. thermophilus that revealed two inde-
pendently folded domains exhibiting a ferredoxin-like fold and
adopting an RRM-like domain. Based on this, the protein was
predicted to function as a nucleic acid-binding protein (Ebihara
et al. 2006). In 2011, the structure of Cas6e from T. thermophilus
bound to repeat RNAs (3′ handle) was determined (Gesner et al.
2011; Sashital et al. 2011). Recently, the structures of two Cas6e
enzymes of T. thermophiluswere solved and showed dimerization
with two RNA substrates bound in the resulting crRNP, further
displaying the differences in RNA recognition and processing by
various Cas6-like enzymes (Niewoehner et al. 2014).
Based on the first Cas6e structure, an invariant histidine
residue (H20) in Cas6e was demonstrated to be essential for the
catalytic process (Brouns et al. 2008). Initially some heterogene-
ity at the 3′ end of the isolated crRNAs was reported (Brouns
et al. 2008), but a later study demonstrated that mature crRNAs
of Type I-E are the result of a single processing step, typically re-
sulting in 61-nt fragments (see below; Jore et al. 2011). Sequence
analysis of crRNA species associated to Cascade demonstrated
that the mature crRNAs are composed of (i) an 8-nt repeat frag-
ment (5′ handle), (ii) a complete spacer sequence (32-nt) and (iii)
a 21-nt repeat fragment consisting of a stable stem loop of seven
base pairs and a four nucleotide loop (3′ handle) (Brouns et al.
2008). Subsequent ESI-MS/MS analysis of the Cascade-bound cr-
RNAs revealed 5′-hydroxyl and 2′-3′ cyclic phosphate termini
(Jore et al. 2011); likewise, crRNAs associated to T. thermophilus
Cas6e have the same 5′ and 3′ termini (Gesner et al. 2011; Sashital
et al. 2011). It was demonstrated that crRNA-mediated guiding of
Cascade to the target DNA relies on the specific base pairing be-
tween crRNA and its complementary DNA strand with displace-
ment of the non-complementary strand, resulting in an R-loop
(Jore et al. 2011). Cryoelectron microscopy analysis and crystal
structures of the crRNA-Cascade complex revealed the display of
crRNA along a backbone of six Cas7 subunits (Wiedenheft et al.
2011a,b; Jackson et al. 2014; Mulepati et al. 2014; Zhao et al. 2014).
This arrangement protects crRNA from degradation and posi-
tions the crRNA to allow high-affinity base pairing of invading
DNA, initially with the seed sequence at the 5′ end of cognate
crRNA (Semenova et al. 2011; Wiedenheft et al. 2011b).
Cas6f
In P. aeruginosa Type I-F, the Csy proteins Csy1, Csy2, Csy3 and
Cas6f assemble into a ribonucleoprotein complex, the function
of which is to facilitate recognition of target DNA by enhanc-
ing crRNA-DNA sequence-specific hybridization (Haurwitz et al.
2010; Rollins et al. 2015). Similar to E. coli Cascade, the complex
has a crescent shape (Haurwitz et al. 2010; Rollins et al. 2015). The
structure of Cas6f bound to crRNA revealed that Cas6f makes
sequence-specific interactions in the major groove of the crRNA
repeat stem loop (Haurwitz et al. 2010). Cas6f binds tightly to
pre-crRNA sequences by exclusive interactions with the hairpin
upstream of the scissile phosphate, allowing Cas6f to generate
crRNA guides for subsequent targeting of DNA (Haurwitz et al.
2010). As observed for the Cas6e (Brouns et al. 2008), binding of
Cas6f to RNA is substrate specific and requires RNAmajor groove
contacts that are highly sensitive to helical geometry. A strict
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preference for guanosine adjacent to the scissile phosphate in
the active sitewas reported to contribute to the selectivitymech-
anism (Haurwitz et al. 2010). Cas6f employs a serine and an
histidine residue to facilitate cleavage of the pre-crRNA within
the repeat at the 3′ side of a stable RNA stem-loop structure
(Haurwitz et al. 2010). Interestingly, unlike the crRNA processing
by E. coli or T. thermophilus Cas6e, crRNAs produced by P. aerugi-
nosa Cas6f have a non-cyclic phosphate at the 3′ end (Wieden-
heft et al. 2011b).
In Type I-C, Cas5d acts as the pre-crRNA
endoribonuclease
The Type I-C locus is characterized by the presence of cas3, cas5d,
cas8c, cas7, cas4, cas1 and cas2 genes, and by the absence of a
cas6-like gene. The molecular basis of pre-crRNA processing in
Type I-C was investigated in Bacillus halodurans and Mannheimia
succiniciproducens (Garside et al. 2012; Nam et al. 2012). Cas5d of
the locuswas identified as the endoribonuclase that cleaves pre-
crRNA within the repeats. Cas5d recognizes both the base of
the pre-crRNA stem loop and the 3′ single-stranded overhang in
the pre-crRNA repeat. Following recognition, Cas5d then cleaves
the substrate into unit length in a metal-independent manner
(Nam et al. 2012). Thus, recognition of the 3′ overhang, which
corresponds to the 5′ handle in the mature crRNA, distinguishes
Cas5d from the Cas6-like enzymes. The cleavage by Cas5d yields
an 11-nt 5′ tag instead of the canonical 8 nt generated by Cas6
enzymes (Garside et al. 2012; Nam et al. 2012; Koo et al. 2013).
Cleavage was reported to generate crRNA products with a 5′ OH
and a 2′,3′-cyclic phosphate. The crystal structure of Cas5d re-
vealed a ferredoxin-based architecture and a catalytic triad con-
sisting of residues Y46, K116 and H117, indicative of a general
acid-base mechanism (Garside et al. 2012; Nam et al. 2012). Addi-
tional biochemical and structural analysis showed that follow-
ing pre-crRNA cleavage, Cas5d assembles into a 400-kDa com-
plex together with the mature crRNA and Cas8c (Csd1) and Cas7
(Csd2), the other two Cas proteins specific to Type I-C. Similar to
Cascade, the Type I-C crRNA-Cas complex would subsequently
act in interference with DNA. Nam et al. also suggested that
pre-crRNA processing by Cas5d and formation of the Type I-C
Cascade-like complex may be spatially and temporally coupled.
Taken together the structural features of Cas5d and the cleav-
age site on pre-crRNA show that Cas5d is distinct from the Cas6-
like endoribonuclases, although the canonical general acid-base
mechanism is applied for processing.
crRNA BIOGENESIS IN TYPE II SYSTEMS
In addition to the adaptation modules Cas1 and Cas2, Type I
and III CRISPR-Cas systems encode CRISPR-specific ribonucle-
ases (Cas6, Cas5d) responsible for crRNA biogenesis and interfer-
ence. In contrast, Type II CRISPR-Cas systems are characterized
by a minimal locus: the CRISPR repeat-spacer array, a unique
cas9 gene as the first gene in an operon containing two or three
cas adaptationmodules (cas1, cas2, csn2 or cas4) and a small RNA,
tracrRNA (Deltcheva et al. 2011; Makarova et al. 2011a,b; Chylin-
ski et al. 2013, 2014). Types II are present in bacteria but absent in
archaea (Makarova et al. 2011a,b), and phylogenetic studies have
resulted in a classification into Types II-A, II-B and II-C (Koonin
and Makarova 2013; Chylinski et al. 2014; Fonfara et al. 2014). The
first biological evidence for CRISPR-Cas immunity was demon-
strated in a Type II-A system of Streptococcus thermophilus against
lytic phages (Barrangou et al. 2007). Subsequently, studies have
shown (i) a role of a Type II-A in the limitation of horizontal gene
transfer (immunity against temperate phages encoding viru-
lence factors) in the human pathogen S. pyogenes (Deltcheva et al.
2011), (ii) a role of a Type II-C in preventing mobile genetic ele-
ment acquisition via natural transformation in Neisseria menin-
gitidis (Zhang et al. 2013) and (iii) an immunity-independent un-
expected role of a Type II-B system in the downregulation of
endogenous expression of a virulence factor encoding mRNA in
Francisella novicida (Sampson et al. 2013). In 2011, it was demon-
strated that Type II CRISPR-Cas systems use a unique crRNA bio-
genesis pathway distinct from Type I and III CRISPR-Cas systems
that involve the coordinated action of three factors: the trans-
acting tracrRNA, the host-encoded RNase III and the Cas9 pro-
tein (Deltcheva et al. 2011). Later in 2013, a study in a Type II-C in
N. meningitidis identified an alternative pathway for guide RNA
biogenesis. In absence of RNase III, the production of crRNA 5′
termini occurs through promoter sequences located within the
repeats of the CRISPR array (Zhang et al. 2013)
tracrRNA trans-activates pre-crRNA cleavage
by the housekeeping endoribonuclease III
in the presence of Cas9
A genome-wide computational analysis aiming to reveal new
small RNAs in a clinical isolate of S. pyogenes revealed tracrRNA
located upstream of the cas genes of a Type II-A system on the
opposite strand. Northern blot followed by differential RNA se-
quencing (dRNA-seq) analysis demonstrated in vivo expression
of precursor and mature forms of the Type II-A tracrRNA and
pre-crRNA (Deltcheva et al. 2011). Low abundance of unique in-
termediate crRNA forms of 66 nt composed of 5′-partial repeat-
spacer-partial repeat-3′ and high abundance mature forms of
39–42 nt consisting of spacer-derived guide sequence in 5′ and
repeat-derived sequence in 3′ were detected. It was proposed
that crRNA biogenesis in Type II-A occurs as a two-step process
with a first cleavage within the repeats and a secondmaturation
of spacer sequences by either cleavage within the spacers at a
specific distance from the first cleavage site and/or by trimming
(Deltcheva et al. 2011). In the same clinical isolate of S. pyogenes,
tracrRNA is expressed in three main forms with two primary
species (181–89 nt) transcribed from two distinct promoters and
a processed form (75 nt), the three species sharing the same
transcriptional terminator. Both primary tracrRNAs share a 25-
nt stretch of almost perfect (one mismatch) complementar-
ity with each of the pre-crRNA repeats. Genetic and dRNA-seq
analysis concluded that tracrRNA and pre-cRNA undergo co-
processing through base pairing of tracrRNA anti-repeat and
pre-crRNA repeats (Deltcheva et al. 2011). Moreover, the study
showed that the 89-nt tracrRNA was the least stable of the two
primary forms of tracrRNA, an indication that it may be the pri-
mary species preferentially processed in vivo. Both co-processed
75-nt tracrRNA and 66-nt intermediate crRNA species carried
short overhangs at the 3′ end, typical for cleavage by the endori-
bonuclease RNase III (Deltcheva et al. 2011). Further genetic and
biochemical analysis confirmed that the endogenous RNase III—
a general RNA processing factor in bacteria—was recruited to
cleave tracrRNA and pre-crRNA upon base pairing and that sta-
bilization of the duplex RNA by the protein Cas9 was required
in the process (Deltcheva et al. 2011). These findings represented
the first description of RNase III-mediated co-processing of two
small non-coding RNAs and consisted of the first example of a
non-Cas protein being recruited to CRISPR activity.
Subsequent work demonstrated that tracrRNA not only plays
a key role in the processing of crRNA in Type II systems but also
forms an essential component of the Cas9 cleavage complex
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(Jinek et al. 2012). In particular, following a second maturation
event of still uncharacterized nature, a mature duplex compris-
ing both crRNA and tracrRNA bound to Cas9 guide the protein
to the invading DNA in a recognition process involving base-
pairing complementarity between the guide crRNA sequence of
the dual-RNA and the cognate target DNA sequence (Jinek et al.
2012). Cas9 was also shown recently to be required during the
phase of adaptation for the selection of spacers by recognizing
the PAM of the protopacers (Heler et al. 2015; Wei et al. 2015).
Cas9 is the signature protein of the Type II systems and does not
share any obvious similarity with the Type I and III Cas proteins
(Makarova et al. 2006, 2011a,b). It is a large protein containing
two nuclease domains, an HNH domain and a split RuvC-like
(RNase H-fold) domain responsible for DNA target cleavage, a
domain for the recognition of the target DNA and an arginine-
rich motif initially suggested to be involved in RNA recogni-
tion (Makarova et al. 2006, 2011a,b; Sapranauskas et al. 2011;
Gasiunas et al. 2012; Sampson et al. 2013; Anders et al. 2014;
Chylinski et al. 2014; Jinek et al. 2014). tracrRNA is the second
signature of the Type II systems. Analysis of bacterial genomes
demonstrated already in 2011 an association of tracrRNA to Type
II CRISPR-Cas loci in a number of commensal and pathogenic
bacteria (Deltcheva et al. 2011; Chylinski et al. 2013, 2014). Ex-
pression and RNase III-mediated co-processing of tracrRNA and
pre-crRNAs were demonstrated in selected bacterial species of
Types II-A, II-B and II-C (Deltcheva et al. 2011; Chylinski et al.
2013, 2014). Anti-repeat and repeat sequences differ significantly
in the analyzed genomes, and the repeat sequences analyzed
share a certain degree of similarity, especially in the terminal
regions and around the putative cleavage site (Deltcheva et al.
2011; Chylinski et al. 2013, 2014). Notably, despite sequence dif-
ferences, the sequence complementarity in anti-repeat:repeat
base pairing is conserved and co-evolution of tracrRNA, crRNA
and the Cas9 protein was further proposed (Deltcheva et al. 2011;
Chylinski et al. 2013, 2014).
An RNase III-independent alternative pathway for
crRNA biogenesis in a Type II-C CRISPR-Cas system
A Type II-C CRISPR-Cas system in N. meningitidis is character-
ized by the presence of an operon of only three cas genes (cas9,
cas1 and cas2) displaying a unique pathway for crRNA biogenesis
(Deltcheva et al. 2011; Zhang et al. 2013). In this system, promoter
sequenceswere predicted embeddedwithin each CRISPR repeat.
It was shown that some of these promoters initiate transcription
in the spacer regions of the CRISPR array yielding intermediate
forms of crRNAs containing 5′PPP termini (Zhang et al. 2013). Fur-
ther genetic and dRNA-seq analysis demonstrated that follow-
ing annealing to tracrRNA through antirepeat:repeat interaction,
RNase III cleaves both strands of the tracrRNA:pre-crRNA du-
plex (Chylinski et al. 2013; Zhang et al. 2013). However, the au-
thors of this study show that pre-crRNA processing is dispens-
able. When RNase III is not available or fails to cleave, Cas9 can
still form functional complexes with tracrRNA and crRNA. Sim-
ilar promoters present within the repeats of a Type II-C CRISPR
array were also observed and described in Campylobacter jejuni
(Dugar et al. 2013; Zhang et al. 2013).
crRNA BIOGENESIS IN TYPE III SYSTEMS
Type III CRISPR-Cas systems are present in both bacteria and ar-
chaea (Makarova et al. 2011a,b). This variant has initially been
studied in the archaeon P. furiosus (Type III-B) by the Terns labora-
tory (Carte et al. 2008,2010; Hale et al. 2008). Later, the biogenesis
of crRNAs has also been investigated in the Gram-positive bac-
terial pathogen Staphylococcus epidermidis (Type III-A) (Hatoum-
Aslan et al. 2011). Interestingly, it was shown that Type III-B sys-
tems do not target DNA sequences but exclusively target ssRNA
(Hale et al. 2012,2014; Zhang et al. 2012). In one of the first demon-
strations of CRISPR-Cas activity, the Type III-A system from S.
epidermidiswas shown to target conjugative plasmid DNA in vivo
(Marraffini and Sontheimer 2008). Recently, it was demonstrated
by several groups that Type III-A systems also target ssRNA in
vitro (Staals et al. 2014; Tamulaitis et al. 2014) and in vivo (Tamu-
laitis et al. 2014).
Like the Type I systems, crRNA production in Type III sys-
tems is dependent on the activity of proteins of the Cas6 family.
Cas6 enzymes are normally an integral subunit of some Type I
(Cascade) systems (for example Cas6e and Cas6f in E. coli and P.
aeruginosa, respectively) (Brouns et al. 2008; Haurwitz et al. 2010).
In contrast, Cas6 enzymes of Types III appear to function in-
dependently of the Cas protein complexes and have not been
observed to co-purify with them. crRNA maturation in Types
III occurs in two steps. In these systems, processing involves
cleavage of pre-crRNA by Cas6 within the repeats, generating
1X intermediate units that undergo further processing at the 3′
end of the crRNA to produce the active mature crRNAs (Carte
et al. 2008,2010), similarly to the trimming of crRNAs in Type I-A
(Plagens et al. 2014) and I-B (Richter et al. 2012). Type III systems
have a backbone of Cas7-like proteins in both Type III-A (Rouil-
lon et al. 2013) and III-B systems (Staals et al. 2013). In both types,
the proteinswere shown to assemble around the crRNAs to form
interference complexes (Csm and Cmr), similar to Cascade of
Type I. After complex formation, the crRNA is facilitated to guide
the crRNP to target ssRNA/dsDNA for Csm (Staals et al. 2014;
Tamulaitis et al. 2014) and ssRNA for Cmr (Hale et al. 2012,2014;
Zhang et al. 2012), respectively.
Type III crRNAs are expressed and processed in vivo
The bacterial Type III-A system
In 2008, Marraffini and Sontheimer showed that initial crRNA
processing generated products of 71 nt in S. epidermidis, sug-
gestive of pre-crRNA cleavage at the base of a potential stem-
loop structure within each repeat. These products were in turn
further trimmed to mature crRNA of 49-nt species by 3′-end
processing (Marraffini and Sontheimer 2008, 2010). Differential
RNA-seq and Northern blot analysis confirmed crRNA produc-
tion and maturation in the T. thermophilus Type III-A and III-B
systems (Juranek et al. 2012).
The archaeal Type III-B system
In 2002, Tang et al. (2002) showed that small RNAs derived from
CRISPR repeats, although then known as SRSRs (short regularly
spaced repeats), were transcribed in the archaeon Archaeoglobus
fulgidus. Ladders of RNA corresponding in length to 1, 2, 3 or
more repeat-spacer units were detected by Northern blot analy-
sis. Similar ladders were subsequently observed in the crenar-
chaeon S. solfataricus (Tang et al. 2005) and in S. acidocaldarius
(Chen et al. 2005; Lillestol et al. 2006, 2009). The authors pro-
posed that SRSRs were transcribed as a precursor RNA that
was further processed to generate the unit length small RNAs.
These studies represented the first experimental evidence for cr-
RNA processing, although the endonuclease, Cas6, was not yet
discovered. Interestingly, Northern blotting and RNA mapping
experiments in S. acidocaldarius and S. solfataricus revealed ex-
pression and processing of RNA molecules from complemen-
tary strands of repeat-spacer arrays into discrete short RNAs of
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length distinct from that of the mature crRNAs (Lillestol et al.
2009). The authors of the study suggested that the antisense
RNAs could either serve as neutralizers of crRNAs in the absence
of invading elements or alternatively be required for the slic-
ing activity of the invaders (Lillestol et al. 2009). The presence
of anti-sense RNAs was also shown for the bacterial I-B system
of C. thermocellum (Richter et al. 2012) and led to the speculation
of regulatory functions by the anti-sense crRNAs (Zoephel and
Randau 2013).
In 2008, pre-crRNA expression and processing was investi-
gated in P. furiosus by the Terns lab (Hale et al. 2008). Small
RNA species primarily of lengths 39 nt and 45 nt were the pre-
dominant, mature crRNA forms identified. An intermediate of
about 65 nt corresponded to pre-crRNA cleaved within the re-
peat sequences, prior to 3′-end processing (Hale et al. 2008). The
same mature species were subsequently identified in the puri-
fied Type III-B complex from P. furiosus (Hale et al. 2012). Analysis
of crRNA co-purifying with the Type III-B complex from S. sol-
fataricus showed the presence of RNA molecules with variable
sizes centered on 46 nt consistent with a first cleavage within
each repeat followed by exonucleolytic digestion at the 3′ end
(Zhang et al. 2012). Small amounts of RNA corresponding to the
reverse complement of pre-crRNAwere also identified in this ex-
periment; however, they constituted just 0.01% of the RNA se-
quenced (Zhang et al. 2012). In addition, pre-crRNA antisense
transcription, probably driven by the presence of functional pro-
moter sequences within spacers, was detected at a significant
level compared to crRNA products in P. furiosus (Hale et al. 2012).
These are thought to function as endogenous target RNA of the
system (Hale et al. 2012).
The endoribonuclease Cas6 cleaves pre-crRNA
within the repeats
The bacterial Type III-A system
Using primer extension and conjugation experiments with a se-
ries of pre-crRNA mutants, the Marraffini group showed that
both the RNA hairpin formation within the repeats and the
sequence 5′-GGGACG-3′ at the base of the stem-loop struc-
ture were needed for efficient primary processing of pre-crRNA
(Hatoum-Aslan et al. 2011). Furthermore, it was shown that not
only Cas6 but also Cas10 (the large subunit of Type III systems)
and Csm4 (the Cas5 subunit of Type III-A systems) were required
for the production of crRNAs in stable form in vivo, suggesting
that the latter maintain the stability of crRNAs (Hatoum-Aslan
et al. 2011). The recent advances in structural analysis of the Type
III-A showed a flexible composition of the Csm complex based
on the length of the crRNA. Flexibility is achieved by varying
amounts of the subunits Csm3 and Csm4 that display the back-
bone of the crRNP. In these studies it is speculated that Csm5,
potentially an integral part of the Csm complex is involved in
the 3′ processing of the crRNA (Rouillon et al. 2013; Staals et al.
2014).
The archaeal Type III-B system
It was demonstrated by the Terns lab that the endoribonu-
clease responsible for crRNA processing in the Type III-B of P.
furiosuswas Cas6, one of the core Cas proteins (Carte et al. 2008).
The Cas6 cleavage site was mapped to a defined position 8 nt
from the 3′ end of the repeat sequence, generating unit length cr-
RNAs (1X intermediates) with a central spacer typically flanked
by 8 nt of repeat-derived sequence at the 5′ end (13-nt 5′ tag in
the case of the cyanobacterium Synechocystis (Scholz et al. 2013)
and a longer repeat sequence (∼ 22 nt) at the 3′ end (Carte et al.
2008). Mature crRNAs isolated from the Type III-B (Cmr) com-
plex from S. solfataricus also began with the 8-nt 5′ handle de-
rived from the CRISPR repeat with spacer-derived sequence at
the 3′ end (Zhang et al. 2012). The 3′ termini of the sequenced
crRNAs showed some variability, with some spacer-derived se-
quences displaying short 3′ handle and others containing little
repeat-derived sequences (Zhang et al. 2012). A similar pattern
was observed for the crRNA isolated from the Type III-A (Csm)
complex (Rouillon et al. 2013). This was in contrast to mature
crRNAs isolated from S. solfataricus Cascade complexes (Type I-
A), which include longer 3′ repeat-derived handles (Lintner et al.
2011). The reasons for these differences are not yet understood,
but may relate to differing extents of protection of the crRNA
intermediates following binding by Type I and Type III effector
complex subunits.
Insights into the structure of the endoribonuclease
Cas6
The crystal structure of P. furiosus Cas6 revealed a duplicated
RRM (ferredoxin-like) fold, with the two halves of the protein
separated by a cleft (Carte et al. 2010). Cas6 is distinguish-
able from the other members of the RAMP family of proteins
by the presence of a predicted G-rich loop motif (consensus
GhGxxxxxGhG, where h is hydrophobic and xxxxx has at least
one lysine or arginine) at the C-terminus (Makarova et al. 2002;
Haft et al. 2005). Within the cleft of Cas6, a catalytic triad, con-
sisting of Y31, H46 and K52, which is conserved in some other
Cas6 proteins, was detected and its importance in the catalytic
mechanism was confirmed by mutagenesis (Carte et al. 2008,
2010). Overall, the fold is related to the Cas6e subunit of the
Type I-E Cascade complex (van der Oost et al. 2009), which per-
forms the same function and produces unit length crRNAs with
the canonical 8-nt repeat-derived 5′ tag (Brouns et al. 2008). Like
Cas6, Cas6e also cleaves RNA in a metal-independent manner.
In contrast to Cas6 having a duplicated ferredoxin fold, the RNA-
bound Cas6f of the Type I-F contains a single ferredoxin fold
(Haurwitz et al. 2010). An active site histidine has also been im-
plicated in the Cas6b, Cas6e and Cas6f nucleases (Brouns et al.
2008; Haurwitz et al. 2010; Richter et al. 2012). Curiously how-
ever, there is no conserved histidine in the crenarchaeal Cas6
orthologs from S. solfataricus (Lintner et al. 2011), suggesting a
different catalytic mechanism may operate in these enzymes.
Site directed mutagenesis coupled with kinetic analyses have
shown that a constellation of basic residues positioned near the
base of the small hairpin formed by bound crRNA contribute to
efficient catalysis (Reeks et al. 2013). Interestingly, Cas6 enzymes
are not always monomers. One form of Cas6 from S. solfataricus
is a dimer (Reeks et al. 2013; Shao and Li 2013), and this is also
the case for Cas6b of M. maripaludis (Richter et al. 2013). The func-
tional significance of these dimeric structures is still unclear.
The structure of P. furiosus Cas6 bound to crRNA revealed that
the first 10 nt of crRNA, which was the only part observed in
the crystal structure, makes sequence-specific interactions with
a conserved binding interface in Cas6 on the face opposite the
catalytic site (Wang et al. 2011). The RNA was predicted to loop
around the protein, before re-engaging at the active site, result-
ing in cleavage of the crRNA between nucleotides A22 and A23.
In the middle, a linker region of the crRNA between residues
10 and 20 can accommodate point mutations, insertions and
deletions without abrogating Cas6 activity, suggesting that it
may not be recognized by the protein (Wang et al. 2011). In con-
trast, the structure of S. solfataricus Cas6 bound to a crRNA re-
vealed specific recognition and stabilization of a short hairpin
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structure in the repeat, with cleavage at the base of the hair-
pin (Shao and Li 2013) similar to the bacterial Cas6 enzymes.
The mode of crRNA recognition by the P. furiosus Cas6 enzyme
thus appears to be an outlier. Several families of Cas6 exist in S.
solfataricus, which differ in their specificity for the two types of
CRISPR repeat encoded in the genome. Thismay provide amech-
anism for specific loading of crRNAs from particular CRISPR
loci into specific effector complexes (Sokolowski et al. 2014). A
similar situation may exist in the cyanobacterium Synechocystis
sp. PCC6803, which has three CRISPR loci, each associated with
genes encoding an effector complex (one Type I-D and two Type
III) and two Cas6 paralogs, each specific for a particular CRISPR
repeat sequence (Scholz et al. 2013).
CONCLUSIONS
The core components of the CRISPR-Cas defense machinery are
the short mature crRNAs that contain signature sequences of
mobile genetic elements and associate with one or more Cas
proteins to target and destroy invading nucleid acids through
crRNA:target sequence specific recognition. The CRISPR repeat-
spacer array is transcribed as a long pre-crRNA that undergoes a
first cleavage within the repeats sometimes followed by an ad-
ditional maturation step. Although this principle is commonly
shared, CRISPR-Cas types have evolved distinct mechanisms for
the biogenesis of mature crRNAs.
Different Cas proteins characteristic for the subtype play dis-
tinct catalytic or assisting functions in the first step of pre-crRNA
processing. Types I and III both use endoribonucleases of the
Cas6 family to cleave the pre-crRNA within the repeats. Both
types encode also a module of several additional Cas proteins,
which in the case of some Type I subsystems form complexes
with the respective Cas6 enzyme. For example, Type I-E encodes
Cse1, Cse2, Cas7 and Cas5, which together with Cas6e and cr-
RNA form Cascade (Ebihara et al. 2006; Brouns et al. 2008; Gesner
et al. 2011; Jore et al. 2011; Sashital et al. 2011; Wang et al. 2011;
Wiedenheft et al. 2011a). The trans-acting nuclease Cas3 is then
recruited to the complex to cleave invading DNA (Beloglazova
et al. 2011; Howard et al. 2011; Mulepati and Bailey 2011; Sinku-
nas et al. 2011;Wiedenheft et al. 2011a;Westra et al. 2012). Type I-F
(Ypest or CASS3) encodes Csy1, Csy2 and Csy3, which together
with Cas6f and crRNA form a crRNP complex, which is likely
to recruit the DNA-cleaving enzyme Cas3 as for Type I-E (Hau-
rwitz et al. 2010; Wiedenheft et al. 2011b; Rollins et al. 2015). The
Type III systems encode a set of Cas proteins that include the
signature protein, Cas10 (formerly Csm1, Cmr2 and Csx11). In
Type III-B, Cas6 functions as a standalone endoribonuclease, and
the associated proteins Cmr1, Cas10, Cmr3, Cmr4, Cmr5 and
Cmr6 interfere downstream of the Cas6-mediated processing
event in target RNA interference (Carte et al. 2008, 2010; Hale
et al. 2008, 2009, 2012, 2014;Wang et al. 2011). In Type III-A, it was
shown that Cas10, Csm2, Csm3 and Csm4 form a complex and
that the action of Csm5 may be required for further processing
of the Cas6-generated intermediate crRNAs to produce the ma-
ture crRNAs (Hatoum-Aslan et al. 2011; Rouillon et al. 2013; Staals
et al. 2014). Interestingly, no Cas6 endoribonuclease is found in
Type I-C. Instead, the protein Cas5d is the endoribonuclease that
processes the pre-crRNAwithin the repeats, using amechanism
distinct from that of Cas6 (Garside et al. 2012; Nam et al. 2012; Koo
et al. 2013). Similar to Cas6 proteins of other Types I, Cas5d as-
sembleswith crRNA and two other Cas proteins, Cas8c and Cas7,
to form a Cascade-like interference complex (Nam et al. 2012).
In contrast, the minimal Type II system uses Cas9 as the only
Cas protein for the steps of crRNA biogenesis and interference
with invading DNA. The system has evolved a trans-acting small
RNA, tracrRNA, which takes advantage of the housekeeping
endoribonuclease III to catalyze tracrRNA-directed cleavage
within the pre-crRNA repeats, involving the stabilization of the
RNA duplex by Cas9 (Deltcheva et al. 2011). The tracrRNA also
forms an essential component of the Cas9 target recognition and
cleavage complex (Jinek et al. 2012). Type II systems are found
exclusively in bacteria and the absence of these systems in ar-
chaea may be explained by the absence of genes encoding en-
doribonuclease III-like activities. The description of a Type II-C
in N. meningitidis that does not require the activity of RNase III
for the maturation of crRNAs is an interesting alternative strat-
egy evolved by bacteria. In this particular case, crRNA forms are
expressed from promoter sequences located within the repeats
of the CRISPR arrays.
CRISPR-Cas systems have evolved mature crRNAs with dis-
tinct subtype-dependent composition and length. In Types I-A
(Cas6a), I-B (Cas6b), I-D (Cas6d), I-E (Cas6e), I-F (Cas6f), and Types
III-A (Cas6) and III-B (Cas6), mature crRNAs are composed of 8 nt
of repeat sequence in 5′ directly followed by invader-targeting
spacer-derived sequence (Brouns et al. 2008; Carte et al. 2008;
Marraffini and Sontheimer 2008; Haurwitz et al. 2010; Plagens
et al. 2014). Accordingly,C. thermocellum andM.maripaludisCas6b,
E. coli, S. solfataricus and T. thermophilus Cas6e, P. aeruginosa Cas6f
and P. furiosusCas6 all cleave exactly 8 nt upstreamof the repeat-
spacer junctionwithin the pre-crRNA repeats (Ebihara et al. 2006;
Brouns et al. 2008; Haurwitz et al. 2010; Gesner et al. 2011; Sashital
et al. 2011). In contrast to Types II and III, Cas6-like-generated cr-
RNAs of Types I-E and I-F do not undergo additional maturation
and are composed of the 8-nt repeat tag at the 5′ end, complete
sequence of the spacer in the middle and the remainder of the
repeat fragment, generally forming a hairpin structure, at the
5′ end (Brouns et al. 2008; Haurwitz et al. 2010). This does not
seem to be a feature of all Type I systems since processing of the
3′ end of the crRNAs was observed for I-A (Plagens et al. 2014)
and I-B (Richter et al. 2012) systems. Furthermore, Cas6 is not an
integral part of the I-A Cascade of T. tenax (Plagens et al. 2014),
leading to the speculation that crRNAs produced by standalone
Cas6 enzymes are generally 3′ trimmed before being loaded to
their respective interference complex. Type III (S. epidermidis, P.
furiosus) mature crRNAs have repeat-derived sequences at the 5′
end and spacer-derived sequence at the 3′ end (Carte et al. 2008;
Marraffini and Sontheimer 2008). A reverse configuration char-
acterizes Type II mature crRNAs that are composed of a spacer-
derived sequence in 5′ and a repeat-derived sequence in 3′
(Deltcheva et al. 2011). Furthermore, Type I, Type II and Type III
systems produce mature crRNAs of distinct sizes (Carte et al.
2008; Marraffini and Sontheimer 2008). Intriguingly, matura-
tion in both Types III-A and III-B generates two distinct crRNA
species. Finally, the crRNAs have different terminal configura-
tions, Type I-C crRNAs in B. halodurans and Type I-E crRNAs in
E. coli have 5′-hydroxyl group and 2′-3′ cyclic phosphate (Jore
et al. 2011) while in P. aeruginosa Type I-F crRNAs terminate with
5′-hydroxyl group and 3′ phosphate (not cyclic) (Haurwitz et al.
2010; Richter et al. 2012; Plagens et al. 2014). Type III-A crRNAs
(S. epidermidis) contain 3′-hydroxyl groups (Hatoum-Aslan et al.
2011) whereas Type III-B crRNAs end with either 3′-hydroxyl or
2′-3′-cyclic phosphate ends (Carte et al. 2008). Several reports
also describe differential expression levels of the individual ma-
ture crRNAs produced from a same CRISPR array. Deep dRNA-
seq studies in Types I and III indicate that the most recently ac-
quired sequences at the leader end of the CRISPR loci appear to
correspond to the most abundant crRNA species (Wurtzel et al.
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2010; Hale et al. 2012; Juranek et al. 2012; Randau 2012; Richter
et al. 2012; Nickel et al. 2013; Soutourina et al. 2013; Su et al. 2013;
Plagens et al. 2014). It has been suggested that differences in pre-
crRNA transcription rates, processing and/or stability could pro-
vide plausible explanations for this observation.
An interesting additional characteristic is the property of pre-
crRNA repeats to fold or not to fold. In 2007, a systematic analysis
of the sequences and RNA folding stabilities of CRISPR repeats
was reported (Kunin et al. 2007). The CRISPR repeats were clas-
sified into 12 major clusters on the basis of conserved sequence
features. The authors noted that the repeats in some clusters
had a pronounced ability to fold into a stable hairpin struc-
ture whilst others lacked this property, and divided CRISPRs
into ‘folded’ and ‘unfolded’ categories. The authors further sug-
gested that the hairpin structures of the repeats might serve
as a motif for Cas protein recognition. With some exceptions,
most of the Type I CRISPR repeats fall into the ‘folded’ cate-
gory whereas Type II and Type III repeats are considered ‘un-
folded’. Type I repeats mostly contain palindromic sequences
predicted to form stable hairpin structures ending upstream of
the cleavage site. Structural analysis demonstrated that P. aerug-
inosa Cas6f interacts specifically with the hairpin to place the
cleavage site at the base of the stem loop within the enzyme
active site (Haurwitz et al. 2010). In 2010, Carte et al. (2010) sug-
gested that the CRISPR repeats of Type III-B in P. furiosus belong
to a group of repeat sequences considered unstructured with
the potential to form weak stem loops. Along these lines, the
same authors showed that in absence of proteins, the pre-crRNA
is predominantly unstructured in solution (Carte et al. 2010).
Analysis of the crRNA-bound Cas6 structure also indicate that
pre-crRNA wraps around the surface of the endoribonuclease,
consistent with the lack of folded structure (Wang et al. 2011).
Even though Cas6 orthologs share extremely low sequence iden-
tity, the ‘wrap around’ mechanism involved in Cas6 recognition
and cleavage of unstructured crRNA could also apply to Type
III-A and potentially to Type I systems with unstructured re-
peats. However, it was suggested that Type III-A repeats of S.
epidermidis form internal hairpins that would enhance crRNA
processing at the binding and/or nucleolytic level (Hatoum-
Aslan et al. 2011). In the case of Type II, base pairing of unstruc-
tured pre-crRNA to tracrRNAmay compensate this deficiency by
providing an intermolecular structure that directs the process-
ing within pre-crRNA repeats (Deltcheva et al. 2011; Chylinski
et al. 2013; Briner et al. 2014).
To conclude, there are numerous variations of crRNA biogen-
esis, mediated by distinct components and mechanisms, which
we have begun to understand only recently. Unique RNA recog-
nition mechanisms enable to discriminate pre-crRNAs from
other cytosolic RNAs. Distinct RNA cleavagemechanisms specif-
ically produce themature guide crRNAs that associate to respec-
tive interference complexes. Future studies will certainly pro-
vide additional details on the crRNA maturation complexes of
the multiple rapidly evolving CRISPR-Cas subtypes and should
shed some light on the molecular mechanisms involved in the
second maturation events.
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